 |
 |
|
 |
|
 |
 |
| Subscriber Login |
 |
RSS Feeds
WA Business News subscriber login
Malaria treatment close
6-August-08
Written by Jamie Burnett
Perth-based Eastland Medical Systems Ltd is a step closer to bringing its revolutionary anti-malaria treatment to market, with African field trials to hopefully begin as soon as September.
ArTiMist, which delivers an already proven ant-malaria drug in a new method, through a spray under the tongue, will be targeted at children and infants who are often unable to digest tablet forms of malaria treatment due to symptoms of the disease shutting down their digestive system.
"When a young child gets malaria they go into shock, so their digestive system ceases to operate and it shuts down, so it doesn't matter what you do, it doesn't work because the metabolisms closed down," Eastland Medical executive director Douglas Sims said.
Article continues...
6-August-08
Written by Jamie Burnett
Perth-based Eastland Medical Systems Ltd is a step closer to bringing its revolutionary anti-malaria treatment to market, with African field trials to hopefully begin as soon as September.
ArTiMist, which delivers an already proven ant-malaria drug in a new method, through a spray under the tongue, will be targeted at children and infants who are often unable to digest tablet forms of malaria treatment due to symptoms of the disease shutting down their digestive system.
"When a young child gets malaria they go into shock, so their digestive system ceases to operate and it shuts down, so it doesn't matter what you do, it doesn't work because the metabolisms closed down," Eastland Medical executive director Douglas Sims said.
Article continues...
Welcome to the new WA Business News website.
We invite you to explore our new site, with its added features and tools. The search capabilities of archives has been upgraded and expanded, includes 17,546 Western Australian business articles totalling 6,497,223 words.
Subscribers to the WA Business News are able to access articles as part of their subscription. If you are not a subscriber you can subscribe online now or you can purchase credits to view the articles. Alternatively you can also request an 8 week free trial of our paper (Note: the 8 week trial does not include website access).
If you are a subscriber or have previously registered with the website and don't know your login details please contact us on +61 8 9288 2100. If you are unsure of your login password please complete the forgot password form
Kind regards
Harry Kleyn - Publisher
 |
| SUBSCRIBE TODAY! |
